Dapagliflozin in Depression

Summary

Major depressive disorder (MDD) is currently one of the leading causes of disability and suicidal death worldwide, and despite extensive research and massive improvements in mental health, the nature of MDD remains ambiguous. Moreover, about two-thirds of MDD patients fail to optimally respond to currently available standard therapies, and many of them suffer from treatment-resistant depression

Timeline

Start

2025-11-01

Primary completion

2026-11-20

Completion

2026-12-20

Drugs

Indications